Meine Merkliste
my.bionity.com  
Login  

Gulf Pharmaceutical Industries P.S.C. (JULPHAR) - Financial and Strategic SWOT Analysis Review

Summary

Gulf Pharmaceutical Industries P.S.C., also known as Julphar, is a publicly held pharmaceutical company. The company focuses on the manufacture of pharmaceutical products. Julphar's products include drugs, medicines, and other various types of pharmaceutical, medical and cosmetic compounds including analgesics, anti-malaria, anti-amoebic, antihistamines, cough and cold preparations, vitamins and steroids. The company owns 11 plants of which nine are in operation and the other two pants are still under construction. The company has over 3,500 products registered in over 50 countries around the world, with 800 formulations and 189 brands. Julphar is headquartered in Ras Al Khaimah, United Arab Emirates.

Juphar's strategic focus is on the development of drugs for the therapeutic disease areas including antibiotics, respiratory, diabetes, cardiovascular, gastroenterology and biotechnology. Recently, the company announced the plans to manufacture insulin at its new $136m plant in Ras Al Khaimah, UAE. The company will manufacture the insulin in partnership with IDF and the production is likely to start in coming weeks.

Gulf Pharmaceutical Industries P.S.C. Key Recent Developments

Feb 02, 2012: PAREXEL And Gulf Pharmaceutical Industries Sign Agreement For Human Recombinant Insulin Project
Aug 18, 2011: Gulf Pharmaceutical Plans To Build $26m Algeria Plant

This comprehensive SWOT profile of Gulf Pharmaceutical Industries P.S.C. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Pharma / Arzneimittel   Marktstudie
Jahrgang:   2012
Herausgeber:   GlobalData
Preis:   125.00€

Marktstudie bestellen

Bestellen Sie die Marktstudie bei markt-studie.de

Merkliste

Hier setzen Sie die nebenstehende Marktstudie auf Ihre persönliche Merkliste.

Mehr über GlobalData
Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.